Tanaka, Yoshiya https://orcid.org/0000-0002-0807-7139
Oba, Koji
Koike, Takao
Miyasaka, Nobuyuki
Mimori, Tsuneyo
Takeuchi, Tsutomu
Hirata, Shintaro https://orcid.org/0000-0002-2474-9943
Tanaka, Eiichi
Yasuoka, Hidekata
Kaneko, Yuko
Murakami, Kosaku
Koga, Tomohiro
Nakano, Kazuhisa
Amano, Koichi
Ushio, Kazuyasu
Atsumi, Tatsuya
Inoo, Masayuki
Hatta, Kazuhiro
Mizuki, Shinichi
Nagaoka, Shouhei
Tsunoda, Shinichiro
Dobashi, Hiroaki
Horie, Nao
Sato, Norihiro
Funding for this research was provided by:
a Research Grant-In-Aid for Scientific Research (Ministry of Health, Labor and Welfare of Japan.)
A radiologic evaluation grant (Mitsubishi Tanabe Pharma Co., Ltd.)
This article is maintained by: Elsevier
Article Title: Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial
Journal Title: Annals of the Rheumatic Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2019-216169
Content Type: article
Copyright: Copyright © 2020 © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.